George Hruby Clinical Oncology Society of Australia Annual Scientific Meeting 2024

George Hruby

A/Prof George Hruby is a radiation oncologist with advanced training, research and clinical specialty interests in both GU and GI cancers. Following a clinical fellowship at the Royal Prince Alfred Hospital in 1999, he was awarded a post-graduate fellowship at the University of Toronto specializing in GU malignancies and prostate brachytherapy. George returned to Australia in Dec 2000 commencing as a Staff Specialist in Radiation Oncology at Royal Prince Alfred Hospital. Whilst at RPAH, he established a close working relationship with Noumean GI and GU colleagues and has treated many New Caledonians with GU and GI malignancies over the years. George established the High Dose Rate brachytherapy program at Royal Prince Alfred Hospital performing over 300 implants since its inception in 2002. Other skills honed include trans-perineal biopsies, fiducial marker placement and inserting hydrogel spacer. George was instrumental in introducing more sophisticated techniques for the treatment of prostate cancer patients such as image guided radiation treatment (IGRT) at RPA. Along with Susan Carroll (at RPA) and Andrew Kneebone at RNSH, George implemented IMRT (intensity modulated radiation treatment) for anal cancer in 2009. Together they published the first internationally published series documenting this treatment in Australia. In 2014 George treated the first patient with SABR (stereotactic ablative body radiotherapy) for oligo-metastatic disease at RPA. In 2014, George was invited to join the specialised radiation oncology (SRO) team as a staff specialist at Royal North Shore, and as a Visiting Radiation Oncologist (VRO) at Genesis Care where he currently treats patients at St Vincents Clinic, and the Health Hub. More recent areas of interest include focal re-treatment of prostate cancer, “virtual HDR”; and the introduction of state of the art imaging such as PSMA-PET for staging, targeting, mapping and assessing the response to RT in prostate cancer. George co-leads the SRO GI service with AK. They have contributed to the Australasian guidelines for the use of stereotactic RT for pancreatic cancer, and have been involved in workshops to establish contouring atlases for SBRT for pancreatic cancer (as well as previous work in rectal and anal cancer). These techniques will roll out in a National trial for the use of sophisticated RT in this disease. Further down the GI tract, George has co-authored the radiation oncology section for the Cancer Council guidelines on managing rectal cancer and over the last 20 years has treated perhaps more anal cancer than any other radiation oncologist in Sydney due to his roles in the GI teams at both RNS and St Vincents hospitals. GH has been heavily involved in national and international trials and is an active participant in AGITG, TROG (and FROGG) and ANZUP where he serves on the scientific advisory committee. GH has authored well over 100 peer reviewed publications and is involved in teaching, mentoring and lecturing.

Abstracts this author is presenting: